Mercury Securities
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Earn MS Coin when you trade with MST28. Check out MST28.
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Get FREE real time quotes on our website & App. Check out MST28.
Open Trading Account
add free Download App
premium Premium Account

Share Price
Buy-Q Buy Sell Sell-Q
premium Premium Account Only
Live Quote
5 market depth level
Live intraday chart
Share Volume VWAP
Change Trade Value Open
Day Range Year Range Ref


TechnicalChart
Market Date: 06 Jul 2022


Market Capital (RM)
Number of Share
EPS (cent)
P/E Ratio
ROE (%)
TTM Profit Margin (%)
CAGR - Revenue (%)
CAGR - PAT (%)
Business+
YoY Score
QoQ Score
Dividend (cent)
Dividend Yield (%)
Dividend Policy (%)
NTA (RM)
P/B Ratio

* Calculated based on the net profit of the trailing twelve months and latest number of shares issued.

Charting

Latest quarter result performance
Revenue
1 YEAR HIGH
2 YEAR HIGH
3 YEAR HIGH
4 YEAR HIGH
5 YEAR HIGH
Profit
1 YEAR HIGH
2 YEAR HIGH
3 YEAR HIGH
4 YEAR HIGH
5 YEAR HIGH

DateFinancial
Year
QuarterRevenue
(RM,000)
PBT (RM,000)Net Profit
(RM,000)
EPS (Cent)Div
(Cent)
NTA
(RM)
QoQ
(%)
YoY
(%)
26 May 2231 Dec 22Q1 Mar 224,163,058621,148493,2595.360.002.540 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
23 Feb 2231 Dec 21Q4 Dec 214,470,716684,159453,5984.906.002.550 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
29 Nov 2131 Dec 21Q3 Sep 214,444,996616,618550,0006.010.002.570 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
26 Aug 2131 Dec 21Q2 Jun 214,270,271668,463483,3065.260.002.530 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
01 Jun 2131 Dec 21Q1 Mar 213,945,780586,497375,6214.040.002.480 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
26 Feb 2131 Dec 20Q4 Dec 203,765,987660,927419,3584.524.002.480 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
26 Nov 2031 Dec 20Q3 Sep 203,518,331395,969309,9523.280.002.420 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
27 Aug 2031 Dec 20Q2 Jun 202,565,110-232,032-120,642-1.640.002.440 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
29 Jun 2031 Dec 20Q1 Mar 203,555,176-257,357-319,786-3.900.002.450 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
28 Feb 2031 Dec 19Q4 Dec 193,836,099195,73140,6300.214.002.550 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
29 Nov 1931 Dec 19Q3 Sep 193,788,364394,263236,3422.440.002.540 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
30 Aug 1931 Dec 19Q2 Jun 193,645,335265,644184,9941.860.002.530 Malaysia Stock - KLSE Quarter Report History Malaysia Stock - KLSE Quarter Report History
1234

Member Only Subscribe today to unlock feature below and many more
Revenue - Record-high quarterly revenue Net Profit - Record-high quarterly profit after tax

Name%SharesPosition
Change
ValueRecord Date
MBK HEALTHCARE MANAGEMENT PTE LTD32.812,888,487,400NEW18.43B31 Mar 22
PULAU MEMUTIK VENTURES SDN BHD25.742,266,086,176NEW14.46B31 Mar 22
EMPLOYEES PROVIDENT FUND BOARD8.54751,282,400-14,637,5004.79B31 Mar 22
THE CENTRAL DEPOSITORY PTE LIMITED6.65585,063,477-2,047,1003.73B31 Mar 22
KUMPULAN WANG PERSARAAN3.40299,174,80012,487,1001.91B31 Mar 22
KUWAIT INVESTMENT AUTHORITY1.70150,000,00021,600957.00M31 Mar 22
AMANAH SAHAM BUMIPUTERA1.18104,000,000-190,096,200663.52M31 Mar 22
GREAT EASTERN LIFE ASSURANCE MALAYSIA BERHAD0.6557,905,9001,181,800369.44M31 Mar 22
STATE STREET BANK & TRUST COMPANY0.6052,670,500-679,400336.04M31 Mar 22
PRULINK EQUITY FUND0.5851,435,3006,076,400328.16M31 Mar 22
Member Only Subscribe today and enjoy full access to the records and other feature.


Dividend Summary
Dividend Growth (%)
Dividend Increasing (Years)
Dividend Continuously (Years)
Charting

DateFinancial
Year
Ex-DateEntitlement
Date
Payment
Date
Entitlement TypeDividend
(Cent)
Dividend
(%)
Details
23 Feb 2231 Dec 2130 Mar 2231 Mar 2229 Apr 22First and Final Dividend6.00000.00 Malaysia Stock -  Dividend
26 Feb 2131 Dec 2030 Mar 2131 Mar 2130 Apr 21First and Final Dividend4.00000.00 Malaysia Stock -  Dividend
28 Feb 2031 Dec 1930 Mar 2031 Mar 2030 Apr 20First and Final Dividend4.00000.00 Malaysia Stock -  Dividend
29 Apr 1931 Dec 1827 Jun 1928 Jun 1918 Jul 19First and Final Dividend3.00000.00 Malaysia Stock -  Dividend
26 Mar 1831 Dec 1727 Jun 1829 Jun 1818 Jul 18First and Final Dividend3.00000.00 Malaysia Stock -  Dividend
27 Mar 1731 Dec 1628 Jun 1730 Jun 1718 Jul 17First and Final Dividend3.00000.00 Malaysia Stock -  Dividend
28 Mar 1631 Dec 1528 Jun 1630 Jun 1618 Jul 16First and Final Dividend3.00000.00 Malaysia Stock -  Dividend
30 Mar 1531 Dec 1401 Jul 1503 Jul 1522 Jul 15First and Final Dividend3.00000.00 Malaysia Stock -  Dividend
15 Apr 1431 Dec 1326 Jun 1430 Jun 1416 Jul 14First and Final Dividend2.00000.00 Malaysia Stock -  Dividend


IHH (5225) : IHH HEALTHCARE BERHAD
CNY2012
Member Star
Posts: 111
Joined: Dec 2011
Male, MYS
07 Nov 2013, 09:02 AMPost #1
Fair value: RM3.80
Hold (maintain)

AMRESEARCH has maintained its “hold” call on IHH Healthcare Bhd with an unchanged fair value of RM3.80 per share, based on a sum-of-parts valuation. The bank-backed research house had a meeting with the management and reaffirmed it believed that operations at new hospitals, besides its expansion plan, were coming along nicely. It also mentioned that IHH’s medium- to long-term catalysts were solid, underpinned by growing bed capacity expansion in Malaysia (+38% beds) and Turkey (+29% beds) that would drive growth for the next few years.

Turkey remains as the group’s biggest growth potential given the fairly fragmented healthcare industry. Following the recent breakeven at the earnings before interest, taxes, depreciation and amortisation (EBITDA) level for Mount Elizabeth Novena and Acibadem Ankara, IHH is looking forward to achieving the same for Acibadem Bodrum by this year.

Another catalyst would be the greenfield hospital in Hong Kong (expected to be operational in 2017), given a circa 25% higher healthcare cost than Singapore. More importantly, IHH could leverage on Hong Kong to penetrate the China market.

By AmResearch
FrancissC
Member Star
Posts: 9
Joined: Aug 2014
Male, MYS
28 Aug 2015, 01:40 PMPost #2
See O'Mighty's opinion on IHH

Like our FB page!

https://www.facebook.com/omightycap/photos/a.516884705141868.1073741828.516880861808919/519860488177623/?type=1&theater

yeah doh drool lol mad notworthy question rant rolleyes sad shutup shy smile star sweat thumbup wub cry
P/E Ratio DY ROE TTM PM Business+ YoY Score QoQ Score
?



Close